Department of Orthopedics, Institute for Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska Hospital, Gothenburg, Sweden.
Stem Cells Dev. 2019 Sep 1;28(17):1203-1211. doi: 10.1089/scd.2019.0074. Epub 2019 Jul 23.
Low back pain is a major health issue and one main cause to this condition is believed to be intervertebral disc (IVD) degeneration. Stem cell therapy for degenerated discs using mesenchymal stromal cells (MSCs) has been suggested. The aim of the study was to investigate the presence and distribution pattern of autologous MSCs transplanted into degenerated IVDs in patients and explanted posttransplantation. IVD tissues from four patients (41, 45, 47, and 47 years of age) participating in a clinical feasibility study on MSC transplantation to degenerative discs were investigated. Three patients decided to undergo fusion surgery at time points 8 months and one patient at 28 months posttransplantation. Pretransplantation, MSCs from bone marrow aspirate were isolated by centrifugation in FICOLL test tubes and cultured (passage 1). Before transplantation, MSCs were labeled with 1 mg/mL iron sucrose (Venofer) and 1 × 10 MSCs were transplanted into degenerated IVDs. At the time point of surgery, IVD tissues were collected. IVD tissue samples were fixated, embedded in paraffin, and sections prepared. IVD samples were stained with Prussian Blue, by which iron deposits are visualized and examined (light microscopy). Immunohistochemistry (IHC), including SOX9 (sex determining region Y box 9), Coll2A1 (collagen 2A1), and cell viability (TUNEL) were performed. Cells positive for iron deposits were observed in IVD tissues (3/4 patients). The cells/iron deposits were observed in clusters and/or as solitary cells in regions in IVD tissue samples [regions of interest (ROIs)]. By IHC, SOX9- and Coll2A1-positive cells were detected in the same regions as the detected cells/iron deposits. A few nonviable cells were detected by TUNEL assay in ROIs. Results demonstrated that MSCs, labeled with iron sucrose, transplanted into degenerated IVDs were detectable 8 months posttransplantation. The detected cellular activity indicates that MSCs have differentiated into chondrocyte-like cells and that the injected MSCs and/or their progeny have survived since the cells were found in large cluster and as solitary cells which were distributed at different parts of the IVD.
下腰痛是一个主要的健康问题,据认为这种情况的一个主要原因是椎间盘(IVD)退变。已经提出使用间充质基质细胞(MSCs)对退变的椎间盘进行干细胞治疗。本研究的目的是调查自体 MSC 移植到退变的 IVD 中并在移植后取出的存在和分布模式。对 4 名参与 MSC 移植到退变椎间盘的临床可行性研究的患者(41、45、47 和 47 岁)的 IVD 组织进行了研究。3 名患者在移植后 8 个月和 1 名患者在 28 个月时决定行融合手术。移植前,通过在 FICOLL 测试管中离心分离骨髓抽吸物中的 MSC 并进行培养(第 1 代)。移植前,将 MSC 用 1mg/ml 蔗糖铁(Venofer)标记,将 1×10 MSC 移植到退变的 IVD 中。在手术时收集 IVD 组织。固定 IVD 组织样本,嵌入石蜡,准备切片。用普鲁士蓝染色 IVD 样本,通过观察和检查铁沉积物(光学显微镜)。进行免疫组织化学(IHC),包括 SOX9(性别决定区 Y 框 9)、Coll2A1(胶原 2A1)和细胞活力(TUNEL)。在 IVD 组织中观察到铁沉积物阳性的细胞(3/4 名患者)。在 IVD 组织样本的 ROI 中,观察到细胞/铁沉积物聚集存在或单个存在。通过 IHC,在与检测到的细胞/铁沉积物相同的区域检测到 SOX9 和 Coll2A1 阳性细胞。在 ROI 中通过 TUNEL 检测到少量非存活细胞。结果表明,标记有蔗糖铁的 MSC 移植到退变的 IVD 中,在移植后 8 个月可检测到。检测到的细胞活性表明 MSC 已分化为软骨样细胞,并且由于细胞以大簇和单个细胞的形式存在,分布在 IVD 的不同部位,因此注射的 MSC 和/或其后代已存活。